✦ LIBER ✦

Screening for neuroblastoma

✍ Scribed by L. Parker

Book ID: 117649871
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 322 KB
Volume: 7
Category: Article
ISSN: 0957-5839
DOI: 10.1016/s0957-5839(97)80176-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

✍ FreimutH. Schilling; Rudolf Erttmann; PeterF. Ambros; Sabine Strehl; Holger Chri 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 427 KB

Screening for neuroblastoma

✍ Alvin M. Mauer 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Japanese mass screening for neuroblastom

Japanese mass screening for neuroblastoma

✍ Kei Kudo; Yumiko Arai; Yoshiaki Kondo 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 22 KB

Value of screening for neuroblastoma?

✍ Louise Parker 📂 Article 📅 1995 🏛 The Lancet 🌐 English ⚖ 172 KB

Colloquy on Neuroblastoma Screening: Is

Colloquy on Neuroblastoma Screening: Is there a future for neuroblastoma mass screening?

✍ Bessho, Fumio 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

It is apparent that mass screening at the age of six months in Japan detects significant numbers of otherwise spontaneously regressing tumors. Nishi et al. estimated that at least 50% of tumors detected by screening with the HPLC method would otherwise regress spontaneously [31]. Considering that no

Mass screening for neuroblastoma in Japa

Mass screening for neuroblastoma in Japan

✍ Sawada, Tadashi; Nishi, Motoi; Takeda, Takeo; Iehara, Tomoko 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

Results of a 11-year-experience with mass screening for neuroblastoma in 6-month-old infants in Japan are presented. From 11,284,837 infants who were screened, 1,400 cases of neuroblastoma were detected, an incidence of 1/ 6,500-7,500 infants by HPLC screening. Most of the cases (75%) were at stages